CURE’s breast cancer page is an extensive resource of cancer information featuring the latest breast cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on breast cancer.
November 21st 2024
Aerobic exercise improved self-reported cognitive function in women undergoing chemotherapy for breast cancer but had no effect on objective cognitive function.
Redefining Success After Breast Cancer
June 13th 2019Breast cancer was one of the best things that ever happened to me – and I never want it again. Now I am cancer-free and living a more fulfilling life than before the illness. Here are 10 insights and experiences from my cancer journey that continue to sustain me professionally and personally.
Komen NYC Educates Women About Breast Cancer Screening
June 6th 2019Linda Tantawi, CEO of Susan G. Komen Greater New York City, discussed the organization’s events that serve as the “pink ribbon connecting the community” and some of their upcoming initiatives to help educate women about breast cancer screening and treatment.
Sharing Information and Support Can Bring Peace and Preparedness
June 5th 2019There is value in information being shared from survivor to survivor. Many health issues may be common, but you can feel alone if you are not aware of them. A well-moderated online support group may be a great place to gain knowledge and comfort.
Kisqali Plus Endocrine Therapy Improves Survival in Breast Cancer Subgroup
June 3rd 2019The addition of Kisqali to standard-of-care endocrine therapy significantly improved overall survival for premenopausal women with advanced HR-positive/HER2-negative breast cancer compared with endocrine therapy alone.
The Phone Calls: Another Friend With Breast Cancer
May 28th 2019As a cancer survivor and advocate, I have gotten the calls that we survivors hate: calls from someone we don’t know who says that a mutual friend told them to call, and friends saying they have been received a diagnosis. I am always ready when the phone rings.
FDA Approves Piqray to Treat Breast Cancer
May 25th 2019The Food and Drug Administration has approved the PI3K inhibitor Piqray (alpelisib) for the treatment of postmenopausal women, and men, with HR-positive, HER2-negative, PIK3CA-mutated, advanced or metastatic breast cancer following progression on or after an endocrine-based regimen.